New implant shows promise for opioid addiction treatment
Disease control
Completed
This early-stage study tested a small implant placed under the skin that releases naltrexone, a medicine used to treat opioid use disorder. Sixteen healthy adults aged 18 to 55 received the implant, which stayed in place for 3 months and was then removed. The main goal was to che…
Phase: PHASE1 • Sponsor: Akyso Therapeutics, LLC • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC